Skip to content
Peripach.com
Menu
  • Home
  • Arts Entertainments
  • Auto
  • Business
  • Cryptocurrency
  • Digital Marketing
  • Education
  • Finance
  • Gaming
  • Health Fitness
  • Home Kitchen
  • Legal Law
  • Lifestyle Fashion
  • Medicine
  • Pets
  • Real Estate
  • Relationship
  • Shopping Product Reviews
  • Sports
  • Technology
  • Tours Travel
  • Privacy Policy
  • Contact US
  • Sitemap
Menu

Weight loss from Eli Lilly’s Zepbound reversed slowly after treatment stopped | Health

Posted on December 11, 2023

Bloomberg | | Posted by Parmita Uniyal

People who stopped taking Eli Lilly & Co.’s Zepbound after about eight months regained half the weight they’d lost a year later, yet were significantly thinner than when they had started the obesity drug, according to a study. Taking Zepbound for 36 weeks resulted in a 20.9% loss of body weight, according to the study published Monday in the Journal of the American Medical Association. But after 88 weeks, a group no longer taking the drug after the first 8 months had still lost 9.9% of their weight. Those who stayed on the drug the entire time lost an average 25.3%. (Also read: Weight loss to cholesterol control; amazing benefits of cumin seeds)

Taking Zepbound for 36 weeks resulted in a 20.9% loss of body weight, according to the study published Monday in the Journal of the American Medical Associatio(Unsplash)

Earlier studies have shown that people who stop taking popular obesity drugs from Lilly and Novo Nordisk A/S called GLP-1s are prone to regaining weight. Still, the results indicate that some benefits are retained a full year later, said Louis Aronne, an obesity expert at Weill Cornell Medicine and lead study author.

Stay tuned with breaking news on HT Channel on Facebook. Join Now

“I was surprised how good the result was,” Aronne said in an interview. He’s a consultant for both Lilly and Novo, which makes the competing weight-loss drug Wegovy. The study clearly shows the need for continual use of these drugs for optimal benefit, Aronne said.

“Patients, providers and the public do not always understand obesity is a chronic disease that often requires ongoing treatment,” Jeff Emmick, Lilly’s senior vice president of product development, said in a statement.

The researchers gave Zepbound for 36 weeks to people with obesity or who were overweight. After that, half the patients were randomly assigned to stay on it for another year while the other half got a placebo. Those who stayed on Zepbound for the full 88 weeks saw their weight loss plateau around the 64-week mark.

Lilly had revealed some of the results of the study in July, but this is the first time the full details have been published.

This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Can Workplace harassment occur outside the office?
  • What is the purpose of a network vulnerability assessment?
  • Is Home Cleaning available for Airbnb homes?
  • Can layoffs affect a federally regulated employee?
  • Which suppliers join global sources trade show 2026?
  • 구글 검색 누락 AI 글 때문인가요?
  • Can customer success staffing agencies find remote talent?
  • 혼자 가도 강남달토는 부담 없는 곳일까?
  • 강남 가라오케 메뉴 뭐 있어요?
  • How do I rebuild confidence after online dating setbacks?
  • 강남호빠는 처음 방문 시 어떻게 하나요?
  • What problems are commonly fixed by Sub-Zero Repair Bay Area technicians?
  • Is severance pay Ontario different from termination pay?
  • Can the TikTok API collect geo-location data?
  • How do I know if I qualify for male boob reduction?
  • Are there premium mobile car cleaning services in Bristol?
  • What material is Airpod Charging Case made from?
  • Are commercial services available for Ductless AC in Coachella Valley, CA?
  • Decentralized Masters: Navigating the 2026 Market Cycle with Discipline
  • Can a Locksmith repair sliding door locks?

Archives

  • July 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023

Categories

  • Arts Entertainments
  • Auto
  • Business
  • Cryptocurrency
  • Digital Marketing
  • Education
  • Finance
  • Gaming
  • Health Fitness
  • Home Kitchen
  • Legal Law
  • Lifestyle Fashion
  • Medicine
  • Pets
  • Real Estate
  • Relationship
  • Shopping Product Reviews
  • Sports
  • Technology
  • Tours Travel
Slot gacor
TOTO SLOT
Slot online
Slot
©2026 Peripach.com | Design: Newspaperly WordPress Theme